Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Thrombolytic Science, LLC, corporate

Thrombolytic Science, LLC,

10.02.2021 - 12:04:02

Thrombolytic Science, LLC: Thrombolytic Science Reinforces Its IP Portfolio with Patents in Europe, the Commonwealth of Independent States and Japan

or contact us at info@tsillc.net


10.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Thrombolytic Science, LLC 763D, Concord Avenue MA 02138 Cambridge

United Kingdom Internet: https://www.tsillc.net/ EQS News ID: 1167348 ? End of News DGAP News Service


@ dgap.de